JPWO2023108129A5 - - Google Patents
Info
- Publication number
- JPWO2023108129A5 JPWO2023108129A5 JP2024534532A JP2024534532A JPWO2023108129A5 JP WO2023108129 A5 JPWO2023108129 A5 JP WO2023108129A5 JP 2024534532 A JP2024534532 A JP 2024534532A JP 2024534532 A JP2024534532 A JP 2024534532A JP WO2023108129 A5 JPWO2023108129 A5 JP WO2023108129A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- tnnc1
- polynucleotide
- promoter
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288255P | 2021-12-10 | 2021-12-10 | |
| US63/288,255 | 2021-12-10 | ||
| PCT/US2022/081282 WO2023108129A1 (en) | 2021-12-10 | 2022-12-09 | Troponin c (tnnc1) gene therapy using aav vector |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024545507A JP2024545507A (ja) | 2024-12-09 |
| JP2024545507A5 JP2024545507A5 (https=) | 2025-10-29 |
| JPWO2023108129A5 true JPWO2023108129A5 (https=) | 2025-10-29 |
Family
ID=86731323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024534532A Pending JP2024545507A (ja) | 2021-12-10 | 2022-12-09 | Ａａｖベクターを用いたトロポニンｃ（ｔｎｎｃ１）遺伝子治療 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240335566A1 (https=) |
| EP (1) | EP4444893A4 (https=) |
| JP (1) | JP2024545507A (https=) |
| CN (1) | CN118613591A (https=) |
| CA (1) | CA3240616A1 (https=) |
| WO (1) | WO2023108129A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3021572A1 (en) | 2016-04-20 | 2017-10-26 | Centro De Investigaciones Energeticas, Medioambientales Y Tecnologicas | Compositions and methods for enhanced gene expression of pklr |
| EP3697452A4 (en) | 2017-10-16 | 2021-11-24 | Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. | LENTIVIRAL VECTORS FOR ADMINISTRATION OF PKLR TO TREAT PYRUVATE KINASE DEFECTS |
| BR112020020841A2 (pt) | 2018-04-11 | 2021-01-19 | Fundacion Para La Investigacion Biomedica Del Hospital Infantil Universitario Nino Jesus | Composições e métodos para transplante de célulastronco |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5553547B2 (ja) * | 2009-07-14 | 2014-07-16 | 俊一 梶岡 | トロポニン含有医薬組成物 |
| AU2012258525B2 (en) * | 2011-05-26 | 2017-02-23 | University Of Washington | Cell and gene based methods to improve cardiac function |
| EP2792742A1 (en) * | 2013-04-17 | 2014-10-22 | Universitätsklinikum Hamburg-Eppendorf (UKE) | Gene-therapy vectors for treating cardiomyopathy |
| CA3057899A1 (en) * | 2017-03-27 | 2018-10-04 | Vrije Universiteit Brussel | Diaphragm-specific nucleic acid regulatory elements and methods and use thereof |
| CN114450411A (zh) * | 2019-04-01 | 2022-05-06 | 特纳亚治疗股份有限公司 | 具有工程化衣壳的腺相关病毒 |
| AR126660A1 (es) * | 2021-07-28 | 2023-11-01 | Univ Brussel Vrije | Mejorando la eficacia de la terapia génica dirigida a músculos |
-
2022
- 2022-12-09 WO PCT/US2022/081282 patent/WO2023108129A1/en not_active Ceased
- 2022-12-09 US US18/718,023 patent/US20240335566A1/en active Pending
- 2022-12-09 CA CA3240616A patent/CA3240616A1/en active Pending
- 2022-12-09 CN CN202280090177.8A patent/CN118613591A/zh active Pending
- 2022-12-09 EP EP22905416.8A patent/EP4444893A4/en active Pending
- 2022-12-09 JP JP2024534532A patent/JP2024545507A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240390519A1 (en) | Plakophilin-2 (pkp2) gene therapy using aav vector | |
| JP2025179046A5 (https=) | ||
| IL278213B1 (en) | A gene therapy vector encoding an e3 ubiquitin protein ligase (park2) and use thereof in treating or inhibiting the onset of parkinson’s disease (pd) | |
| JPWO2022032226A5 (https=) | ||
| JP2021533805A5 (https=) | ||
| US20260049336A1 (en) | Bicistronic aav vectors encoding hexosaminidase alpha and beta-subunits and uses thereof | |
| JP2024099770A5 (https=) | ||
| JP2023088902A5 (https=) | ||
| JPWO2020014523A5 (https=) | ||
| JP2021520232A5 (https=) | ||
| JP2023065516A5 (https=) | ||
| JPWO2022031756A5 (https=) | ||
| JPWO2023108129A5 (https=) | ||
| JPWO2020041773A5 (https=) | ||
| JPWO2020167996A5 (https=) | ||
| JPWO2023108029A5 (https=) | ||
| JPWO2022018171A5 (https=) | ||
| JPWO2023205767A5 (https=) | ||
| RU2024134795A (ru) | Генная терапия ассоциированным с в-клеточной лимфомой 2 антаногеном 3 (bag3) с использованием вектора aav | |
| RU2024118774A (ru) | Генная терапия в отношении тропонина c (tnnc1) с применением вектора на основе aav | |
| JPWO2022015715A5 (https=) | ||
| RU2025121437A (ru) | Генная терапия для плакофилина-2 (pkp2) с применением вектора на основе aav | |
| RU2023105139A (ru) | Генная терапия в отношении плакофилина-2 (pkp2) с применением вектора на основе aav | |
| JPWO2023154763A5 (https=) | ||
| JPWO2022035903A5 (https=) |